These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 16567993)
1. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1. Armenian SH; Han JY; Dunaway TM; Church JA Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993 [TBL] [Abstract][Full Text] [Related]
2. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B; J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732 [TBL] [Abstract][Full Text] [Related]
3. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children. Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071 [TBL] [Abstract][Full Text] [Related]
6. Varicella vaccination in HIV-1-infected children after immune reconstitution. Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018 [TBL] [Abstract][Full Text] [Related]
8. Varicella zoster virus: vaccination and implications in children with renal failure. Fadrowski JJ; Furth SL Expert Rev Vaccines; 2004 Jun; 3(3):291-8. PubMed ID: 15176945 [TBL] [Abstract][Full Text] [Related]
9. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Krause PR; Klinman DM Nat Med; 2000 Apr; 6(4):451-4. PubMed ID: 10742154 [TBL] [Abstract][Full Text] [Related]
10. The effect of vaccination on the epidemiology of varicella zoster virus. Edmunds WJ; Brisson M J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726 [TBL] [Abstract][Full Text] [Related]
11. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP). Goulleret N; Mauvisseau E; Essevaz-Roulet M; Quinlivan M; Breuer J Vaccine; 2010 Aug; 28(36):5878-82. PubMed ID: 20600487 [TBL] [Abstract][Full Text] [Related]
12. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine. Watson B J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388 [TBL] [Abstract][Full Text] [Related]
13. Development of varicella vaccine. Takahashi M; Asano Y; Kamiya H; Baba K; Ozaki T; Otsuka T; Yamanishi K J Infect Dis; 2008 Mar; 197 Suppl 2():S41-4. PubMed ID: 18419406 [TBL] [Abstract][Full Text] [Related]
14. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus]. Bonmarin I; Santa-Olalla P; Lévy-Bruhl D Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741 [TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of VZV infections in patients with HIV. Gershon AA Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015 [TBL] [Abstract][Full Text] [Related]
17. A review of the varicella vaccine in immunocompromised individuals. Sartori AM Int J Infect Dis; 2004 Sep; 8(5):259-70. PubMed ID: 15325594 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age. Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796 [TBL] [Abstract][Full Text] [Related]